106 related articles for article (PubMed ID: 25000562)
1. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
Ciucci A; Meco D; De Stefano I; Travaglia D; Zannoni GF; Scambia G; Riccardi R; Saran A; Mancuso M; Gallo D
PLoS One; 2014; 9(7):e101623. PubMed ID: 25000562
[TBL] [Abstract][Full Text] [Related]
2. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways.
Mancuso M; Leonardi S; Giardullo P; Pasquali E; Borra F; Stefano ID; Prisco MG; Tanori M; Scambia G; Majo VD; Pazzaglia S; Saran A; Gallo D
Cancer Lett; 2011 Sep; 308(2):197-202. PubMed ID: 21636213
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C
Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353
[TBL] [Abstract][Full Text] [Related]
4. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma.
Belcher SM; Ma X; Le HH
Endocrinology; 2009 Mar; 150(3):1112-21. PubMed ID: 19008315
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.
Cookman CJ; Belcher SM
Endocrinology; 2015 Jul; 156(7):2395-408. PubMed ID: 25885794
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists.
Krom YD; Pires NM; Jukema JW; de Vries MR; Frants RR; Havekes LM; van Dijk KW; Quax PH
Cardiovasc Res; 2007 Jan; 73(1):217-26. PubMed ID: 17141206
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β.
Grassi D; Bellini MJ; Acaz-Fonseca E; Panzica G; Garcia-Segura LM
Endocrinology; 2013 Jun; 154(6):2092-100. PubMed ID: 23584859
[TBL] [Abstract][Full Text] [Related]
8. Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity.
Somjen D; Katzburg S; Sharon O; Knoll E; Hendel D; Stern N
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):226-30. PubMed ID: 21397017
[TBL] [Abstract][Full Text] [Related]
9. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes.
Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY
Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing.
Peržeľová V; Sabol F; Vasilenko T; Novotný M; Kováč I; Slezák M; Ďurkáč J; Hollý M; Pilátová M; Szabo P; Varinská L; Čriepoková Z; Kučera T; Kaltner H; André S; Gabius HJ; Mučaji P; Smetana K; Gál P
Int J Mol Med; 2016 Jan; 37(1):21-8. PubMed ID: 26397183
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
[TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism in medulloblastoma features.
Zannoni GF; Ciucci A; Marucci G; Travaglia D; Stigliano E; Foschini MP; Scambia G; Gallo D
Histopathology; 2016 Mar; 68(4):541-8. PubMed ID: 26132417
[TBL] [Abstract][Full Text] [Related]
14. High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not.
Prieto LM; Brown JW; Perez-Stable C; Fishman LM
Horm Metab Res; 2008 May; 40(5):311-4. PubMed ID: 18491249
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.
Hershberger PA; Stabile LP; Kanterewicz B; Rothstein ME; Gubish CT; Land S; Shuai Y; Siegfried JM; Nichols M
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):102-9. PubMed ID: 19460433
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Raffetto JD; Qiao X; Beauregard KG; Khalil RA
J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696
[TBL] [Abstract][Full Text] [Related]
17. Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery.
Vornehm ND; Wang M; Abarbanell A; Herrmann J; Weil B; Tan J; Wang Y; Kelly M; Meldrum DR
Surgery; 2009 Aug; 146(2):145-54. PubMed ID: 19628068
[TBL] [Abstract][Full Text] [Related]
18. Dilatory responses to estrogenic compounds in small femoral arteries of male and female estrogen receptor-beta knockout mice.
Cruz MN; Douglas G; Gustafsson JA; Poston L; Kublickiene K
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H823-9. PubMed ID: 16183727
[TBL] [Abstract][Full Text] [Related]
19. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
[TBL] [Abstract][Full Text] [Related]
20. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
